We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+1.31%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$100M
AUM Growth
-$233K
Cap. Flow
+$2.63M
Cap. Flow %
2.63%
Top 10 Hldgs %
20.23%
Holding
305
New
56
Increased
128
Reduced
51
Closed
53

Sector Composition

Rank Sector Weight
1 Healthcare 42.59%
2 Industrials 10.06%
3 Real Estate 8.71%
4 Technology 8.48%
5 Financials 5.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYM icon
76
Vanguard High Dividend Yield ETF
VYM
$80B
$459K 0.46%
3,096
+183
+6% +$27.5K
ALNY icon
77
Alnylam Pharmaceuticals
ALNY
$35.7B
$453K 0.45%
1,370
+75
+6% +$25.5K
TEM
78
Tempus AI
TEM
$9.42B
$452K 0.45%
+10,000
New +$568K
DWX icon
79
State Street SPDR S&P International Dividend ETF
DWX
$525M
$450K 0.45%
9,861
+176
+2% +$8.08K
KYMR icon
80
Kymera Therapeutics
KYMR
$9.52B
$445K 0.44%
5,342
+307
+6% +$24.3K
NEM icon
81
Newmont
NEM
$95.8B
$436K 0.44%
4,028
+200
+5% +$23.1K
UMAC icon
82
Unusual Machines
UMAC
$809M
$434K 0.43%
35,000
-15,000
-30% -$228K
COR icon
83
Cencora
COR
$59.9B
$424K 0.42%
1,350
+355
+36% +$124K
PSNL icon
84
Personalis
PSNL
$1.61B
$408K 0.41%
64,032
+16,236
+34% +$137K
L icon
85
Loews
L
$23.6B
$407K 0.41%
3,811
+2,554
+203% +$273K
CLDX icon
86
Celldex Therapeutics
CLDX
$2.77B
$400K 0.4%
+12,614
New +$344K
NRIX icon
87
Nurix Therapeutics
NRIX
$2.4B
$396K 0.4%
25,571
+7,437
+41% +$123K
CAH icon
88
Cardinal Health
CAH
$53.5B
$394K 0.39%
1,865
+566
+44% +$122K
RZLV
89
Rezolve AI
RZLV
$921M
$384K 0.38%
150,000
-75,000
-33% -$212K
ABVX
90
Abivax
ABVX
$11.9B
$381K 0.38%
+3,424
New +$405K
PFF icon
91
iShares Preferred and Income Securities ETF
PFF
$13.3B
$376K 0.38%
12,386
-1,303
-10% -$40.8K
PRCT icon
92
Procept Biorobotics
PRCT
$1.09B
$375K 0.37%
15,000
-10,000
-40% -$282K
CYTK icon
93
Cytokinetics
CYTK
$10.9B
$370K 0.37%
5,616
+305
+6% +$19.4K
HCA icon
94
HCA Healthcare
HCA
$82.3B
$362K 0.36%
764
+496
+185% +$250K
KGC icon
95
Kinross Gold
KGC
$27B
$350K 0.35%
11,462
+3,731
+48% +$122K
SYRE icon
96
Spyre Therapeutics
SYRE
$8.7B
$335K 0.33%
+6,634
New +$250K
JNJ icon
97
Johnson & Johnson
JNJ
$609B
$320K 0.32%
+1,310
New +$305K
RDW icon
98
Redwire
RDW
$2.02B
$319K 0.32%
+37,500
New +$367K
SHYG icon
99
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.61B
$318K 0.32%
7,524
+968
+15% +$41.3K
JNK icon
100
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.36B
$317K 0.32%
3,307
+415
+14% +$40.2K

Similar funds

AlphaCentric Advisors's Q1 2026 Portfolio in Review

As of Q1 2026, AlphaCentric Advisors held 305 positions worth $100M, down 0.23% from $100M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

AlphaCentric Advisors's Q1 2026 filing shows 56 new, 128 increased, 51 reduced and 53 closed positions. Its largest new stake was Builders FirstSource: 10,000 shares worth $823K. The largest sale was iShares MBS ETF, an estimated $2.48M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 41% a quarter earlier, followed by Industrials and Real Estate.

  • AlphaCentric Advisors's largest Q1 2026 buy was Builders FirstSource: 10,000 shares worth $823K.
  • AlphaCentric Advisors added most to iShares Russell 1000 Value ETF in Q1 2026, an estimated $749K increase.
  • AlphaCentric Advisors's biggest Q1 2026 reduction was AMREP Corp, cutting an estimated $486K.
  • AlphaCentric Advisors fully exited iShares MBS ETF in Q1 2026, selling an estimated $2.48M.
  • AlphaCentric Advisors's ten largest holdings make up 20% of its $100M portfolio in Q1 2026.
  • AlphaCentric Advisors opened 56 new positions and closed 53 in Q1 2026.
  • AlphaCentric Advisors's portfolio value fell 0.23% quarter-over-quarter to $100M.

Based on AlphaCentric Advisors's 13F filing for Q1 2026, filed 7 May 2026.